Adverse events due to drug consumption can damage the physical and mental wellbeing of patients and are a huge economic burden for the healthcare system (Sultana et al., 2013).
In this new episode of the mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Steven Powell, CEO of Ribonexus, a new company put together to develop and ultimately commercialis
Recent discoveries and advances in pharma for lower demand illnesses/indications have resulted in an increase in the number of smaller start-up organisations.
